TY - JOUR
T1 - Intense 18F-fluoride accumulation in liver metastases from a neuroendocrine tumor after peptide receptor radionuclide therapy
AU - Świȩtaszczyk, Cyprian
AU - Prasad, Vikas
AU - Baum, Richard P.
PY - 2012/4
Y1 - 2012/4
N2 - A 48-year-old female patient with a liver-metastasizing neuroendocrine tumor of pancreas underwent restaging with F-fluoride PET/CT after peptide receptor radionuclide therapy. The study detected 4 intense activity enhancements in the liver. These corresponded to 4 of altogether 9 liver metastatic lesions. The fluoride-positive lesions were calcified. Additionally, in pretherapeutic PET scans with 18F-FDG as well as with 68Ga-DOTA-NOC, they presented with doughnut sign and with more avid accumulation of 18F-FDG.
AB - A 48-year-old female patient with a liver-metastasizing neuroendocrine tumor of pancreas underwent restaging with F-fluoride PET/CT after peptide receptor radionuclide therapy. The study detected 4 intense activity enhancements in the liver. These corresponded to 4 of altogether 9 liver metastatic lesions. The fluoride-positive lesions were calcified. Additionally, in pretherapeutic PET scans with 18F-FDG as well as with 68Ga-DOTA-NOC, they presented with doughnut sign and with more avid accumulation of 18F-FDG.
KW - Ga-DOTA-NOC receptor PET/CT
KW - calcification
KW - fluoride PET/CT
KW - liver metastases
KW - neuroendocrine tumor
KW - pancreas
KW - peptide receptor radionuclide therapy
UR - http://www.scopus.com/inward/record.url?scp=84858129747&partnerID=8YFLogxK
U2 - 10.1097/RLU.0b013e3182478a50
DO - 10.1097/RLU.0b013e3182478a50
M3 - Article
C2 - 22391729
AN - SCOPUS:84858129747
SN - 0363-9762
VL - 37
SP - e82-e83
JO - Clinical nuclear medicine
JF - Clinical nuclear medicine
IS - 4
ER -